Noventra Pharma MT2 Melanotan II multi-dose pen and packaging on a reflective surface with a dark background.
Noventra Pharma MT2 Melanotan II multi-dose pen set on a dark background
Noventra Pharma MT2 Melanotan II multi-dose pen

Noventra MT2 Melanotan II – 2ml Multi Dose Pen (200 Clicks)

R 540.00
Add to WishlistCompare

visa master maestro visaelectron ozow

Noventra MT2 Melanotan II is a peptide formulation designed to support enhanced melanin production for deeper, darker, and more even tanning results. This advanced peptide is commonly used by individuals seeking accelerated tanning while reducing the amount of UV exposure typically required to achieve desired skin tone results.

Melanotan II may help promote more consistent pigmentation, improved skin tone, and longer-lasting tanning effects. The peptide is also researched for its role in stimulating melanocortin receptors associated with pigmentation and tanning response.

The convenient 2ml Multi Dose Pen with 200 clicks allows for precise and controlled dosing through subcutaneous administration. MT2 is commonly used in tanning protocols designed to gradually build and maintain skin pigmentation while supporting a customizable tanning experience.

Key Features

Contains Melanotan II (10mg)


Supports natural melanin production


Helps accelerate tanning results


Promotes darker, more even skin tone


Supports longer-lasting bronzing effects


May reduce required UV exposure


Multi-dose pen delivery system


Precise dosing with 200 clicks


Convenient subcutaneous administration


Designed for gradual tanning protocols

Dosage & Usage

LOW


  • 0.25mg

  • Approximately 5 clicks

  • Beginner / fair skin protocol

MED


  • 0.5–1.0mg

  • Approximately 10–20 clicks

  • Standard protocol

MAX


  • 1.0–1.5mg

  • Approximately 20–30 clicks

  • Experienced protocol

Recommended Protocol

Week 1 – Loading


  • 0.25mg

  • 3x per week

  • Approximately 5 units

Week 2 – Build Up


  • Increase from 0.5mg (10 units) up to 1.0mg (20 units) if tolerated

  • 3x per week

Continued Use


  • Gradually titrate dosage until desired color is achieved

Maintenance


  • 0.25–0.5mg weekly

  • Approximately 5–10 units to maintain color

Administration Notes


  • Route: Subcutaneous injection

  • Injection areas: Abdomen or thigh

  • Best taken in the evening to reduce nausea

  • Start with the lowest dose to assess tolerance

  • Rotate injection sites regularly

  • Gradual sun exposure may enhance results

  • Store refrigerated at all times
FAQ's & Tips

What is MT2 Melanotan II used for?

MT2 is commonly used to support accelerated tanning, deeper pigmentation, and more even skin tone.

How is MT2 administered?

The product is administered through subcutaneous injection using the multi-dose pen system.

How quickly does MT2 work?

The image suggests noticeable tanning results may develop within days when combined with gradual sun exposure.

Does MT2 replace sun exposure?

No. Gradual UV exposure is still typically used to stimulate tanning effects while using Melanotan II.

Can MT2 help reduce sun exposure time?

The peptide is commonly researched for its potential ability to enhance tanning efficiency and reduce the amount of UV exposure needed.

How should MT2 be stored?

The image notes that the product should be refrigerated at all times.

Research

Melanocortin Receptor Activity

Melanotan II is a synthetic melanocortin peptide researched for its ability to stimulate melanocortin receptors involved in melanin production and pigmentation.

Skin Pigmentation Support

Studies suggest Melanotan II may increase melanin synthesis, potentially supporting faster tanning responses and deeper pigmentation.

UV Exposure & Tanning

Research has explored whether Melanotan II may help reduce the amount of UV exposure needed to achieve tanning results compared to traditional tanning methods alone.

Additional Research Areas

Melanotan II has also been investigated in broader melanocortin-related research involving appetite, energy regulation, and physiological signaling pathways.

Research into peptide therapies is ongoing and individual responses may vary.

Reviews